Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Johnson and Johnson
Novartis
Teva
Daiichi Sankyo
Covington
Medtronic
Cerilliant
Cipla

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071093

« Back to Dashboard

NDA 071093 describes THIOTHIXENE, which is a drug marketed by Am Therap, Mylan, Sandoz, Watson Labs, Alpharma Us Pharms, Paco, Teva, Teva Pharms, and Cycle Pharms Ltd, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the THIOTHIXENE profile page.

The generic ingredient in THIOTHIXENE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.
Summary for 071093
Tradename:THIOTHIXENE
Applicant:Mylan
Ingredient:thiothixene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 071093
Medical Subject Heading (MeSH) Categories for 071093
Suppliers and Packaging for NDA: 071093
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THIOTHIXENE thiothixene CAPSULE;ORAL 071093 ANDA Mylan Pharmaceuticals Inc. 0378-1001 0378-1001-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1001-01)
THIOTHIXENE thiothixene CAPSULE;ORAL 071093 ANDA Mylan Pharmaceuticals Inc. 0378-2002 0378-2002-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2002-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 23, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1MG
Approval Date:Jun 23, 1987TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2MG
Approval Date:Jun 23, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Mallinckrodt
McKesson
UBS
Medtronic
US Army
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot